JS
Therapeutic Areas
Protomer Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Glucose-Responsive Insulin Receptor Agonist | Diabetes | Pre-clinical (integrated into Lilly pipeline) |
Leadership Team at Protomer Technologies
AM
Alborz Mahdavi, PhD
CEO
RS
Ryan Spencer, PhD
Chemistry
DC
Diao Chen, PhD
Chemistry
SM
Sachin Mali, PhD
Chemistry